The expression and role of SUZ12 in lung adenocarcinoma
Cancer Medicine · 2024-10 · 13 (19)
DOI: 10.1002/cam4.70190 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Medicine, online erschienen am 13.10.2024. Verfasst von Xingsheng Hu und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, Affiliated Hospital of North Sichuan Medical College, Nanchong, China. Hauptthemen laut MEDLINE: Adenocarcinoma of Lung, Polycomb Repressive Complex 2, Lung Neoplasms, Neoplasm Proteins. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
SUZ12 is one of the core members of the polycomb repressive complex 2 (PRC2), but its expression and role in lung adenocarcinoma (LUAD) are unclear. We aimed to explore the expression, prognosis, biological functions and roles of SUZ12 in LUAD.
Methods
The expression of SUZ12 was detected by immunohistochemical staining, qRT‐PCR, and western blotting in LUAD tissues and cells. The biological functions and molecular mechanisms of SUZ12 were characterized by a range of in vitro and in vivo experiments.
Results
SUZ12 was overexpressed in LUAD tissues, and high SUZ12 expression was correlated with worse clinicopathological features and a poorer prognosis. Knockdown of SUZ12 significantly inhibited cell growth, colony formation, invasion, and migration, and induced apoptosis and G1/S phase arrest, while overexpression of SUZ12 had the opposite effects. Knockdown of SUZ12 decreased the tumorigenic capacity of A549 cells in vivo. The expression of key signaling molecules related to the cell cycle, apoptosis, migration, and immunity were altered by the knockdown or overexpression of SUZ12. SUZ12 can directly bind to the Bax promoter region, EZH2 and H3K27me3 levels dependents on SUZ12. The expression levels of SUZ12 and Bax were negatively correlated in LUAD tissues.
Conclusions
SUZ12 is a new oncogene related to the poor prognosis of LUAD. SUZ12 regulates LUAD progression by regulating the expression of related signaling molecules, and as a part of the PRC2 complex, it may bind to the Bax promoter to silence Bax expression.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Oncology, Affiliated Hospital of North Sichuan Medical College, Nanchong, China.
- Department of Oncology, the Second Xiangya Hospital of Central South University, Changsha, China.
- Department of Dermatology, Beijing Anzhen Hospital Affiliated to Capital Medical University, Nanchong Hospital (Nanchong Central Hospital and The Second Clinical Medical School of North Sichuan Medical College), Nanchon…
ORCID-Profile: Xingsheng Hu, Chunhong Hu, Ping Zhong
Zitieren
APA
Hu, X., Hu, C., & Zhong, P. (2024). The expression and role of SUZ12 in lung adenocarcinoma. Cancer Medicine, 13(19). https://doi.org/10.1002/cam4.70190
Vancouver
Hu X, Hu C, Zhong P. The expression and role of SUZ12 in lung adenocarcinoma. Cancer Medicine. 2024;13(19). doi:10.1002/cam4.70190
BibTeX
@article{Hu2024,
author = {Hu, Xingsheng and Hu, Chunhong and Zhong, Ping},
title = {The expression and role of SUZ12 in lung adenocarcinoma},
journal = {Cancer Medicine},
year = {2024},
volume = {13},
number = {19},
doi = {10.1002/cam4.70190}
}
EUVIMED